IKNA Share Price Performance
US$17.16
-0.60 (-3.38%)
Price US$17.16
Share Pricen/a
Ikena Oncology, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
IKNA Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Ikena Oncology, Inc. Key Details
About IKNA
- Founded
- 2016
- Employees
- 9
- CEO
- WebsiteView website
Ikena Oncology, Inc., an oncology company, focuses on developing therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance. It develops IK-595, a molecular glue designed to trap MEK and RAF in an inactive complex. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts.
